Association between Serum Cystatin C and Vascular Complications in Type 2 Diabetes Mellitus without Nephropathy |
Kim, Hye Jeong
(Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine)
Byun, Dong Won (Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine) Suh, Kyoil (Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine) Yoo, Myung Hi (Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine) Park, Hyeong Kyu (Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine) |
1 | Pucci L, Triscornia S, Lucchesi D, Fotino C, Pellegrini G, Pardini E, Miccoli R, Del Prato S, Penno G. Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. Clin Chem 2007;53:480-8. DOI |
2 | Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:1359-66. DOI |
3 | Domingueti CP, Fuzatto JA, Foscolo RB, Reis JS, Dusse LM, Carvalho MDG, Gomes KB, Fernandes AP. Association between Von Willebrand factor, disintegrin and metalloproteinase with thrombospondin type 1 motif member 13, d-Dimer and cystatin C levels with retinopathy in type 1 diabetes mellitus. Clin Chim Acta 2016;459:1-4. DOI |
4 | He R, Shen J, Zhao J, Zeng H, Li L, Zhao J, Liu F, Jia W. High cystatin C levels predict severe retinopathy in type 2 diabetes patients. Eur J Epidemiol 2013;28:775-8. DOI |
5 | Wong CW, Teo BW, Lamoureux E, Ikram MK, Wang JJ, Tai ES, Sethi S, Wong TY, Sabanayagam C. Serum cystatin C, markers of chronic kidney disease, and retinopathy in persons with diabetes. J Diabetes Res 2015;2015:404280. |
6 | Koenig W, Twardella D, Brenner H, Rothenbacher D. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 2005;51:321-7. DOI |
7 | Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care 1998;21:143-56. DOI |
8 | Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 2007;115:173-9. DOI |
9 | Triki S, Fekih O, Hellara I, Neffati F, Douki W, Hamda KB, Maatouk F, Najjar MF. Association between serum cystatin C levels and cardiovascular disease in type 2 diabetic patients. Ann Biol Clin (Paris) 2013;71:438-42. |
10 | Xu Z, Leng C, Yang B, Wang H, Sun J, Liu Z, Yang L, Ge W, Zhu J. Serum cystatin C is associated with large cerebral artery stenosis in acute ischemic stroke. Oncotarget 2017;8:67181-8. |
11 | Paraoan L, Hiscott P, Gosden C, Grierson I. Cystatin C in macular and neuronal degenerations: implications for mechanism(s) of age-related macular degeneration. Vision Res 2010;50:737-42. DOI |
12 | Im E, Venkatakrishnan A, Kazlauskas A. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. Mol Biol Cell 2005;16:3488-500. DOI |
13 | Mussap M, Plebani M. Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci 2004;41:467-550. DOI |
14 | Yang S, Song L, Zhao L, Dong P, Lai L, Wang H. Predictive value of cystatin C in people with suspected or established coronary artery disease: a meta-analysis. Atherosclerosis 2017;263:60-7. DOI |
15 | World Health Organization: 10 Facts on diabetes. Available from: http://www.who.int/features/factfiles/diabetes/en/ (updated 2016 Apr). |